Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs | ||
| dc.conicet.fuente | Elsevier | |
| dc.conicet.organizacion | National Institute of Allergy and Infectious Diseases | |
| dc.conicet.organizacion | National Institute of Allergy and Infectious Diseases | |
| dc.conicet.organizacion | National Center For Toxicological Research. Food And Drug Administration | |
| dc.conicet.organizacion | National Institute of Allergy and Infectious Diseases | |
| dc.conicet.organizacion | National Institute of Allergy and Infectious Diseases | |
| dc.conicet.organizacion | National Center For Toxicological Research. Food And Drug Administration | |
| dc.conicet.organizacion | National Institute of Allergy and Infectious Diseases | |
| dc.conicet.organizacion | National Institute of Allergy and Infectious Diseases | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Histología y Embriología de Mendoza Dr. Mario H. Burgos. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas. Instituto de Histología y Embriología de Mendoza Dr. Mario H. Burgos | |
| dc.conicet.organizacion | National Center For Toxicological Research. Food And Drug Administration | |
| dc.conicet.organizacion | University of Illinois at Urbana | |
| dc.conicet.organizacion | National Institute of Allergy and Infectious Diseases | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.produccionid | 8066743 | |
| dc.contributor.author | Kosik, Ivan | |
| dc.contributor.author | Ince, William L. | |
| dc.contributor.author | Gentles, Lauren E. | |
| dc.contributor.author | Oler, Andrew J. | |
| dc.contributor.author | Kosikova, Martina | |
| dc.contributor.author | Angel, Matthew | |
| dc.contributor.author | Magadan, Javier Guillermo | |
| dc.contributor.author | Xie, Hang | |
| dc.contributor.author | Brooke, Christopher B. | |
| dc.contributor.author | Yewdell, Jonathan W. | |
| dc.date.accessioned | 2019-11-29T21:00:01Z | |
| dc.date.available | 2019-11-29T21:00:01Z | |
| dc.date.issued | 2018-01 | |
| dc.date.updated | 2019-10-21T20:07:16Z | |
| dc.description.abstract | Rapid antigenic evolution enables the persistence of seasonal influenza A and B viruses in human populations despite widespread herd immunity. Understanding viral mechanisms that enable antigenic evolution is critical for designing durable vaccines and therapeutics. Here, we utilize the primerID method of error-correcting viral population sequencing to reveal an unexpected role for hemagglutinin (HA) glycosylation in compensating for fitness defects resulting from escape from anti-HA neutralizing antibodies. Antibody-free propagation following antigenic escape rapidly selected viruses with mutations that modulated receptor binding avidity through the addition of N-linked glycans to the HA globular domain. These findings expand our understanding of the viral mechanisms that maintain fitness during antigenic evolution to include glycan addition, and highlight the immense power of high-definition virus population sequencing to reveal novel viral adaptive mechanisms. | es |
| dc.description.fil | Fil: Kosik, Ivan. National Institute of Allergy and Infectious Diseases; Estados Unidos | |
| dc.description.fil | Fil: Ince, William L.. National Institute of Allergy and Infectious Diseases; Estados Unidos. National Center For Toxicological Research. Food And Drug Administration; Estados Unidos | |
| dc.description.fil | Fil: Gentles, Lauren E.. National Institute of Allergy and Infectious Diseases; Estados Unidos | |
| dc.description.fil | Fil: Oler, Andrew J.. National Institute of Allergy and Infectious Diseases; Estados Unidos | |
| dc.description.fil | Fil: Kosikova, Martina. National Center For Toxicological Research. Food And Drug Administration; Estados Unidos | |
| dc.description.fil | Fil: Angel, Matthew. National Institute of Allergy and Infectious Diseases; Estados Unidos | |
| dc.description.fil | Fil: Magadan, Javier Guillermo. National Institute of Allergy and Infectious Diseases; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Histología y Embriología de Mendoza Dr. Mario H. Burgos. Universidad Nacional de Cuyo. Facultad de Ciencias Médicas. Instituto de Histología y Embriología de Mendoza Dr. Mario H. Burgos; Argentina | |
| dc.description.fil | Fil: Xie, Hang. National Center For Toxicological Research. Food And Drug Administration; Estados Unidos | |
| dc.description.fil | Fil: Brooke, Christopher B.. University of Illinois at Urbana; Estados Unidos | |
| dc.description.fil | Fil: Yewdell, Jonathan W.. National Institute of Allergy and Infectious Diseases; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Kosik, Ivan; Ince, William L.; Gentles, Lauren E.; Oler, Andrew J.; Kosikova, Martina; et al.; Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs; Public Library of Science; Plos Pathogens; 14; 1; 1-2018; 1-19; e1006796 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1553-7366 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/91035 | |
| dc.journal.ciudad | San Francisco | es |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 1-19; e1006796 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Plos Pathogens | es |
| dc.journal.volume | 14 | es |
| dc.language.iso | eng | es |
| dc.publisher | Public Library of Science | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1371/journal.ppat.1006796 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006796 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | INFLUENZA | es |
| dc.subject | HEMAGGLUTININ | es |
| dc.subject | ANTIBODY ESCAPE | es |
| dc.subject | VIRAL EVOLUTION | es |
| dc.subject.classification | Virología | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.423649d7-ce69-402d-9945-07cc77272de0_A.pdf
- Tamaño:
- 7.6 MB
- Formato:
- Adobe Portable Document Format